More Articles

Soaring generics prices come under increased scrutiny Generics/General | Posted 27/04/2015

The US Department of Health and Human Services (HHS) is to investigate the soaring prices of generics in the US.

Generics group established first voice for biosimilars in Canada Biosimilars/General | Posted 27/04/2015

The Canadian Generic Pharmaceutical Association (CGPA), which represents Canada’s generics industry, announced on 7 April 2015 that it had set up a new CGPA Biosimilars Board, with Mr Michel Robido...

Growing investment in Vietnam Pharma News | Posted 27/04/2015

Cyprus-based generics company Medochemie is building its second factory in Vietnam. Construction on the site, which will occupy 44,700 square metres, is expected to be completed by the end of 2015...

Arguments for same INN for biosimilars presented at WHO meeting Biosimilars/General | Posted 17/04/2015

The World Health Organization recently held its 60th Consultation on International Nonproprietary Names (INN) for Pharmaceutical Substances. At the meeting the issue of naming of biologicals, inclu...

Physicians’ views on biosimilars labelling Reports | Posted 17/04/2015

On 23 March 2015, the Alliance for Safe Biologic Medicines (ASBM), which represents patients and physicians, as well as originator biological and biosimilars companies in the US, released results o...

EMA rejects comparators from outside EEA for insulin biosimilars Guidelines | Posted 17/04/2015

The European Medicines Agency (EMA) released its finalized guideline on the non-clinical and clinical development of insulin biosimilars in March 2015 [1]. However, while the guidance took into acc...

More US state legislation on biosimilars substitution Policies & Legislation | Posted 17/04/2015

The US Food and Drug Administration (FDA) gave marketing authorization to its first biosimilar in March 2015 [1]. In anticipation of such an approval, many US states are considering, or have introd...

Safety and cost considerations of generic and originator gabapentin Generics/Research | Posted 17/04/2015

The launch of generic garbapentin prompted researchers from the Chulalongkorn University and the King Chulalongkorn Memorial Hospital in Bangkok, Thailand, to carry out a study to compare the safet...